Radhakrishnan Karthik 4
4 · Monopar Therapeutics · Filed Oct 30, 2024
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-10-28$16.25/sh+1,550$25,188→ 1,550 total
Footnotes (1)
- [F1]The price reported in Column 4 is the Public offering price in the prospectus dated October 28, 2024.